Company · CIK 1814140
Apexigen, Inc.
| CIK | 1814140 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-06-07 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-266846 | 2022-08-12 | 2023-04-07 | 4 | |
| 333-266847 | 2022-08-12 | 2023-04-07 | 4 | |
| 333-269912 | 2023-02-22 | 2023-03-21 | 3 | |
| 333-246287 | 2020-08-14 | 2021-01-29 | 6 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-04-07 | EFFECTDeclared effective | 333-266847 | 9999999995-23-000864 |
| 2023-04-07 | EFFECTDeclared effective | 333-266846 | 9999999995-23-000863 |
| 2023-03-21 | EFFECTDeclared effective | 333-269912 | 9999999995-23-000622 |
| 2023-03-17 | S-1/AAmendment | 333-269912 | 0001193125-23-073842 |
| 2023-02-22 | S-1Registration filed | 333-269912 | 0001193125-23-044843 |
| 2022-09-09 | EFFECTDeclared effective | 333-266847 | 9999999995-22-002645 |
| 2022-09-09 | EFFECTDeclared effective | 333-266846 | 9999999995-22-002644 |
| 2022-09-01 | S-1/AAmendment | 333-266846 | 0001193125-22-236626 |
| 2022-09-01 | S-1/AAmendment | 333-266847 | 0001193125-22-236622 |
| 2022-08-12 | S-1Registration filed | 333-266847 | 0001193125-22-220084 |
| 2022-08-12 | S-1Registration filed | 333-266846 | 0001193125-22-220082 |
| 2022-07-05 | EFFECTDeclared effective | 333-264222 | 9999999995-22-001963 |
| 2021-01-29 | 424B4Final prospectus | 333-246287 | 0001213900-21-005202 |
| 2021-01-28 | EFFECTDeclared effective | 333-246287 | 9999999995-21-000318 |
| 2021-01-07 | S-1/AAmendment | 333-246287 | 0001213900-21-000934 |
| 2020-08-26 | S-1/AAmendment | 333-246287 | 0001213900-20-023862 |
| 2020-08-24 | S-1/AAmendment | 333-246287 | 0001213900-20-023306 |
| 2020-08-14 | S-1Registration filed | 333-246287 | 0001213900-20-022212 |
| 2020-07-17 | DRSDraft made public | 377-03301 | 0001213900-20-017827 |